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Abstract:  Down syndrome (DS) is caused by trisomy of human chromosome 
21 (Hsa21) and is correlated with various comorbidities, including Alzheimer’s 
disease in 50% of affected individuals. The Tc1 mouse model contains a copy 
of Hsa21, producing an animal model of DS. In an effort to understand the 
correlation between DS and Alzheimer’s disease, this study compared the 
learning and memory abilities with hippocampal and cortical brain pathology in 
the Tc1 mouse model. Genotyping of Tc1 mice indicated that Hsa21 was 
transmitted with a 25.0% frequency. Tc1 mice underwent open field, dark-light, 
and step down test of inhibitory avoidance tests at set timepoints. Acquisition of 
a hippocampal-dependent short-term memory task was intact while long-term 
memory trended towards impairment. Relative brain weight of Hsa21 positive 
subjects was significantly higher than control littermates with lateral ventricle 
area profoundly increased. Histological screening for Alzheimer’s-like 
neuropathology showed neurofibrillary tangles in the cortex of all Hsa21+ mice 
and a diffuse plaque in one Hsa21+ subject. Immunohistochemistry was used 
to analyze β-amyloid 1-42 levels in control and Hsa21+ mice. This 
heterogeneity in pathology is consistent with the spectrum of neuropathological 
deficits, including Alzheimer’s, seen in patients with DS. 
Background: Down syndrome (DS) encompasses the majority of live born 
chromosomal abnormalities and is the foremost cause of intellectual disability 
of genetic origin.1 Hsa21 is considered “gene poor,” making up only 1-1.5% of 
the human genome.2,3 Trisomy of Hsa21 results in an additional copy of genes, 
amplifying production rates 1.5 to 3 times normal levels.4 This causes the 
variable phenotype of DS, largely characterized by cognitive deficits. The 
amyloid precursor protein (APP)5. The overexpression of APP leads to 
neurofibrillary tangles (NFTs), β-amyloid plaques, and memory impairments as 
seen in early-onset Alzheimer's disease (AD) at thirty years of age.6   
The B6129S-Tc(Hsa21)1TybEmcf/J, or Tc1, mouse contains a copy of Hsa21 in 
its genome, and is trisomic for these genes, resulting in an animal model of 
Down syndrome. This study evaluated the learning abilities and Alzheimer-like 
anatomical features of the Tc1 model of Down syndrome. Specifically, brain 
regions affected by Alzheimer’s or Down syndrome pathology were sought in 
correlation with short-term and long-term memory impairments. It was expected 
that Alzheimer’s-like pathology would manifest as diffuse or dense β-amyloid 
plaques in the basal ganglia and that short-term memory impairments would be 
the result of hippocampal abnormalities while long-term impairments would be 
due to cortical pathology.14, 13 
Abstract and Background 
 This study has demonstrated that Hsa21 is passed on to offspring at a low 
transmission rate (25.0% in surviving offspring and 19.0% overall), and that the 
fertility rate of the Hsa21+ Tc1 females was lower (1-6 mice per litter) than most 
mouse strains in our colony (8-16). The mortality rate of Tc1 offspring was also 
high, over 25%. Non-surviving offspring may have been severe cases of DS, 
contributing to poor survival. Hsa21+ mothers also may have had difficulty in 
properly caring for offspring. Oxytocin levels were measured via an ELISA 
assay (data not shown) because its reduction is associated infanticide in mice.7 
No change in serum levels were found, although phase of the estrus cycle was 
not recorded and may have masked differences. 
  Hypoactivity was not a confounding variable on the step-down test as 
demonstrated by a lack of change in training step down latency (Figure 3). 
Further, abnormal stress response in Hsa21+ mice should not have interfered 
with memory test results, due to no significant behavioral alterations in the 
dark-light test for anxiety (Figure 4). Memory assessment in Hsa21+ mice only 
showed significant impairments at the 7 day retest (Figure 3). The absence of 
memory deficits at 42 day and 90 day retests was unanticipated, but likely due 
to carry over effects and extinguishing of the learned behavior in both groups. 
These findings indicate that acquisition of learning and short-term memory are 
intact (24 hour retest) while long-term memory is impaired in Hsa21+ mice.13 
 Successful learning at the 24 hour retention test indicates that the  
morphological changes (but not area) in the hippocampus in Hsa21+ animals 
did not interfere with short term memory (Figure 6). This is supported by the 
finding of no change in spine density (Figure 9) and a lower occurrence of 
Alzheimer’s pathology (Figure 7) in the hippocampus. Impaired memory at the 
7 day retest correlates with increased Alzheimer-like pathology (e.g., more 
neurofibrillary tangles) in the cortex (Figure 7). Surprisingly, no change in β-
amyloid binding was identified by immunohistochemistry and there was none of 
the expected striatal pathology. In addition, relative brain weight was found to 
be increased (Figure 5), opposite of what would be expected in severe AD. This 
increase in relative brain weight was especially surprising due to the stark 
increase in size of the lateral ventricles (Figure 6). A trend towards decreased 
β-actin binding was seen in Hsa21+ animals. This protein is expressed in 
dendritic spines, and its decreased abundance may have been an effect of the 
variable spine density in Hsa21+ subjects (Figure 8).12    
 In summary, long-term memory was impaired while short-term memory 
remained intact in the Hsa21+ Tc1 mouse model of Down syndrome. Both 
cortical and hippocampal abnormalities were found in Hsa21+ mice. Current lab 
work is being directed at clarifying long-term memory deficits and cortical 
pathology. APP overexpression cannot fully account for the memory 
impairments in Hsa21+ animals. Due to the lack of significant β-amyloid 
pathology as measured by two different assays, the effect of injecting β-amyloid 
1-42 into C57Bl/6J and Tc1 mouse lines is also being investigated. An analysis 
of  spine density analysis is underway to help clarify these findings. Future work 
will shift from APP to neuronal connectivity induced pathology to explain the 




Figure 7. Bielschowsky stain in Hsa21+ subjects showed (a) neurofibrillary 
tangles in the cortex and 66.67% in the hippocampi. One of three controls 
showed neurofibrillary tangles in the cortex and hippocampus. (b) A diffuse β-
amyloid plaque  found in the cortex of one Hsa21+ at 60x magnification. No 
pathology was found in the basal ganglia  
References 
Animals: 
Breeder pairs of B6129S-Tc(Hsa21)1TybEmcf/J mice were purchased from the 
Jackson Laboratory (Bar Harbor, ME) at six weeks of age and raised in our 
colony until 10 weeks of age before breeding. First generation offspring were 
tested at 25 days, 42 days, and 90 days in a longitudinal design (Figure 1). 
Behavioral Testing: 
Training for the step-down test was performed on animals 25 days old. Subjects 
were placed on a raised platform in the operant chamber, and the time until the 
animal stepped off the platform with all four paws was recorded (step-down 
latency). At this  time, a 0.18 mV shock was administered. Twenty-four hours 
later, the animal was placed on the raised platform again and the step down 
latency time was recorded. This process was repeated 7 days after training and 
when the animals reached 42 and 90 days of age. (Figure 1). After the final 
step-down retention test, subjects were individually placed in a dark-light 
chamber for five minutes. The emergence latency, number of transitions, and 
time in the light were recorded. 
Genotyping and Histology: 
After the 90 day testing, mice were euthanized and samples of brain, tissue, and 
blood samples (oxytocin and thyroxine ELISA assays) were obtained. 
Genotyping via PCR and gel electrophoresis was completed to identify mice that 
were carriers of Hsa21. Histology stains consisted of Bielschowsky’s stain (Aβ 
plaques and NFTs), cresyl violet (morphology), and Golgi (dendritic spine 
density). 
Rabbit polyclonal anti-β-amyloid 1-42 antibody (ab10148) from Abcam 
(Cambridge, MA) was diluted at a 1:50 ratio and incubated over 20 µm coronal 
tissue sections. A control of 1:100 anti-β actin (rabbit monoclonal) from Cell 
Signal (Danvers, MA) . Tissues were incubated overnight at 4⁰C. Tissues were 
incubated with anti-rabbit IgG, HRP-linked Antibody #7074 from Cell Signal at 
22oC for 2-3 hours, and then developed with Opti-4CN for 30 minutes. Images 
were processed in ImageJ (NIH). Stained regions were selected and measured 
for light transmittance. As a background control, an unstained region on the 
same image and of the same area was also measured for transmittance. 
Experimental Methods 
Figure 2. Gel electrophoresis  on a 1.5% agarose gel after PCR. Internal 
positive control  shows up at 324 bp, while the 205 bp band was an amplified 
segment from Hsa21, indicating Hsa21+ subjects.  Hsa21 was passed on to 
offspring at a 25.0% transmission rate in surviving offspring. 
Figure 9. Spine density 
(spine count over length in 
pixels along a dendrite) was 
not significantly different in 
the entorhinal cortex 
(t(4)=0.622, p=0.568) or in the 
CA1 region of the 
hippocampus (t(4)=1.331, 
p=0.248) in Hsa21+ mice 
compared to control 
littermates.  
Figure 5. Relative brain weight 
was found by dividing brain 
weight (mg) by body weight (g) 
on day of sacrifice. Hsa21+ 
mice had a significantly higher 
relative brain weight than 
Hsa21- littermates 
(t(20)=2.491, p<0.05). 
Figure 4. Dark-light testing indicated no 
difference in emergence latency 
(t(19)=0.098, p=0.923), time spent in the 
lighted chamber (t(19)=0.741, p=0.468), or 
the number of transitions (data not shown) 
between chambers (t(19)=0.015, p=0.988)  
in Hsa21+ animals compared to control 
littermates. 
Figure 3. Step-down test of inhibitory avoidance  showed Hsa21+ animals did 
not differ in step-down latency in training nor significantly differ at the 24 hour 
retest compared to controls. A significantly shorter step-down latency  in 
Hsa21+ compared to controls at the 7 day retention test (t(20)=1.807, p<0.05) 
by one-way independent t test. This effect went away at later retention points. 
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Figure 1. Timeline of testing sequence for F1 generation Tc1 offspring. 
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Figure 8. Cortical golgi staining of (a) a control animal with extensive dendritic 
projections and spines at 60x magnification. (b) DS mouse with abnormal 
decreases in the number of dendrites and spines. This deficit was not seen in 
the other two Hsa21+ subjects.  
Figure 6. Cresyl violet stain of the hippocampus and lateral ventricle at 4x 
magnification of (a) a Hsa21- subject and a (b) Hsa21+ showed no change in 
hippocampus area (t(6)=0.371, p=0.730), but a greater than 400% increase in 
lateral ventricles area (t(6)=1.164, p=0.309).  
Figure 10. Immunohistochemistry with 
antibodies against β-amyloid 1-42 did  not 
show different binding intensities between 
(a) Hsa21+ animals or (b) Hsa21- animals 
(t(8)=0.104, p=0.920) in the hippocampus 
and cortex (shown at 60x magnification). 
As a control, β-actin binding was also 
measured.  Hsa21+ β-actin binding (c) 
had a trend towards increased 
transmittance and less binding than (d) 
control littermates (t(8)=0.539, p=0.605).  
The ratio of β-amyloid  transmittance to β-
actin transmittance was also not 
significant (t(8)=0.497, p=0.638) although 
this adjustment indicated a trend in more 
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